Peterson CM - Search Results

1

Rhodotorulic acid--investigation of its potential as an iron-chelating drug.

Grady RW, Peterson CM, Jones RL, Graziano JH, Bhargava KK, Berdoukas VA, Kokkini G, Loukopoulos D, Cerami A. Grady RW, et al. Among authors: peterson cm. J Pharmacol Exp Ther. 1979 Jun;209(3):342-8. J Pharmacol Exp Ther. 1979. PMID: 108388

2

Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid.

Peterson CM, Graziano JH, Grady RW, Jones RL, Markenson A, Lavi U, Canale V, Gray GF, Cerami A, Miller DR. Peterson CM, et al. Exp Hematol. 1979 Feb;7(2):74-80. Exp Hematol. 1979. PMID: 371974 Clinical Trial.

3

Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia major.

Peterson CM, Graziano JH, Grady RW, Jones RL, Vlassara HV, Canale VC, Miller DR, Cerami A. Peterson CM, et al. Br J Haematol. 1976 Aug;33(4):477-85. doi: 10.1111/j.1365-2141.1976.tb03566.x. Br J Haematol. 1976. PMID: 1009020

4

Effects of iron chelators and iron overload on Salmonella infection.

Jones RL, Peterson CM, Grady RW, Kumbaraci T, Cerami A, Graziano JH. Jones RL, et al. Among authors: peterson cm. Nature. 1977 May 5;267(5606):63-5. doi: 10.1038/267063a0. Nature. 1977. PMID: 323727 No abstract available.

5

Clinical trials with 2,3-dihydroxybenzoic acid.

Peterson CM, Jones RL. Peterson CM, et al. Birth Defects Orig Artic Ser. 1976;12(8):187-92. Birth Defects Orig Artic Ser. 1976. PMID: 1009232 No abstract available.

6

Clinical management of thalassemia. The status of new iron chelators.

Cerami A, Grady RW, Peterson CM, Bhargava KK. Cerami A, et al. Among authors: peterson cm. Ann N Y Acad Sci. 1980;344:425-35. doi: 10.1111/j.1749-6632.1980.tb33682.x. Ann N Y Acad Sci. 1980. PMID: 6446872 Review. No abstract available.

7

Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth.

Jones RL, Peterson CM, Grady RW, Cerami A. Jones RL, et al. Among authors: peterson cm. J Exp Med. 1980 Feb 1;151(2):418-28. doi: 10.1084/jem.151.2.418. J Exp Med. 1980. PMID: 6985950 Free PMC article.

8

2,3-DHB ineffective in treatment of iron overload.

Peterson CM, Grady RW, Jones RL, Cerami A, Graziano JH, Markenson AL, Lavi U, Canale V, Gray GF, Miller DR. Peterson CM, et al. N Engl J Med. 1977 Dec 22;297(25):1404. doi: 10.1056/nejm197712222972518. N Engl J Med. 1977. PMID: 337140 Clinical Trial. No abstract available.

9

Inhibition of platelet function with 2,3-dihydroxybenzoic acid.

Greenberg M, Grady RW, Peterson CM. Greenberg M, et al. Among authors: peterson cm. Br J Haematol. 1977 Dec;37(4):569-77. doi: 10.1111/j.1365-2141.1977.tb01030.x. Br J Haematol. 1977. PMID: 603780

10

Studies on the reduction of sputum viscosity in cystic fibrosis using an orally absorbed protected thiol.

Tabachnik NF, Peterson CM, Cerami A. Tabachnik NF, et al. Among authors: peterson cm. J Pharmacol Exp Ther. 1980 Aug;214(2):246-9. J Pharmacol Exp Ther. 1980. PMID: 6248631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters